QA: Pliant Therapeutics INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001746473_2026_Pliant_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001746473, Pliant Therapeutics INC

  xvar xval
0 AssetsCurrent 196,448,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,940,000
3 remainder_Assets 25,840,000
4 LiabilitiesCurrent 16,365,000
5 LiabilitiesNoncurrent 27,658,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 30,475,325
9 ResearchAndDevelopmentExpense 106,201,065
10 remainder_Expenses 2,359,915
11 remainder_Revenues 0
12 remainder_NetIncome 8,162,359
13 remainder_ComprehensiveNetIncome -207,458
  yvar yval
0 Assets 225,228,000
1 Liabilities 44,023,000
2 Expenses 139,036,305
3 Revenues 0
4 StockholdersEquity 181,205,000
5 NetIncome -130,873,946
6 ComprehensiveNetIncome -130,977,675
7 BaseVar 208,328,561
8 EconomicCapitalRatiobeforeLimitedLiability 1.96
9 EconomicCapitalRatio 3.00

Edgar->Model Mapping

Feature Distribution

Change over Time